69 related articles for article (PubMed ID: 8925998)
21. [Detection of genetic mutations in clinical specimens from cancer patients: comparison of NIRCA and SSCP scanning methods].
Botezatu IV; Kondratova VN; Cherkes VL; Barsukov IuA; Aliev VE; Shelepov VP; Likhtenshteĭn AV
Vopr Onkol; 2007; 53(5):549-53. PubMed ID: 18154119
[TBL] [Abstract][Full Text] [Related]
22. K-ras mutations and the diagnosis of pancreatic carcinoma.
Robinson RA
Am J Clin Pathol; 1996 Mar; 105(3):257-9. PubMed ID: 8602603
[No Abstract] [Full Text] [Related]
23. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C
Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001
[TBL] [Abstract][Full Text] [Related]
24. Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis.
Al-Jehani RM; Jeyarajah AR; Hagen B; Hogdall EV; Oram DH; Jacobs IJ
J Natl Cancer Inst; 1998 Apr; 90(7):540-2. PubMed ID: 9539251
[No Abstract] [Full Text] [Related]
25. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient.
Ito K; Watanabe K; Nasim S; Sasano H; Sato S; Yajima A; Silverberg SG; Garrett CT
Gynecol Oncol; 1996 Nov; 63(2):238-46. PubMed ID: 8910634
[TBL] [Abstract][Full Text] [Related]
26. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
27. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
[TBL] [Abstract][Full Text] [Related]
28. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
29. [Determination of K-ras gene mutation in colorectal cancer tissue by capillary electrophoresis].
Shi D; Wang R; Xie H; Tian W; Jia Z; Guo J
Se Pu; 2013 Jun; 31(6):582-6. PubMed ID: 24063200
[TBL] [Abstract][Full Text] [Related]
30. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
Knowles MA; Williamson M
Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
[TBL] [Abstract][Full Text] [Related]
31. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Suzuki Y; Orita M; Shiraishi M; Hayashi K; Sekiya T
Oncogene; 1990 Jul; 5(7):1037-43. PubMed ID: 2197591
[TBL] [Abstract][Full Text] [Related]
32. [Mutation analysis of K-ras protooncogene in colorectal adenocarcinomas and polyps in Russian patients].
Amosenko FA; Korchagina EL; Matveeva TI; Vaganov IuE; Vlasov SB; Poltavets NV; Veselov VV; Gar'kavtseva RF; Poliakov AV
Genetika; 2010 May; 46(5):700-8. PubMed ID: 20583607
[TBL] [Abstract][Full Text] [Related]
33. K-ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcome.
Semczuk A; Berbeć H; Kostuch M; Cybulski M; Wojcierowski J; Baranowski W
J Cancer Res Clin Oncol; 1998; 124(12):695-700. PubMed ID: 9879831
[TBL] [Abstract][Full Text] [Related]
34. K-RAS point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma.
Kruszewski W; Kowara R; Rzepko R; Warezak C; Zieliński J; Gryglewski G; Kopacz A; Jastrzebski T; Pawełczyk T
Folia Histochem Cytobiol; 2004; 42(3):173-9. PubMed ID: 15493579
[TBL] [Abstract][Full Text] [Related]
35. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
[TBL] [Abstract][Full Text] [Related]
36. A comparative investigation of DNA strand breaks, sister chromatid exchanges and K-ras gene mutations induced by cadmium salts in cultured human cells.
Mourón SA; Grillo CA; Dulout FN; Golijow CD
Mutat Res; 2004 Dec; 568(2):221-31. PubMed ID: 15542109
[TBL] [Abstract][Full Text] [Related]
37. [Ras gene analysis in mammary tumors of dogs by means of PCR-SSCP and direct genomic analysis].
Castagnaro M
Ann Ist Super Sanita; 1995; 31(3):337-41. PubMed ID: 8712577
[TBL] [Abstract][Full Text] [Related]
38. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
[TBL] [Abstract][Full Text] [Related]
39. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
40. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.
Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]